Evidence map›Paper›PMID 41746219›Full record

ArticleThe Journal of cell biology2026

Hoi1 targets BLTP2 to ER-PM contact sites to regulate lipid homeostasis.

Samantha K Dziurdzik, Vaishnavi Sridhar, Hailey Eng, Sarah D Neuman, Junran Yan, Michael Davey, Stefan Taubert, Arash Bashirullah, Elizabeth Conibear

Abstract read
In one paragraph

Article in The Journal of cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Mechanistic dissection of BLTP2 targeting to ER-PM contact sites.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Samantha K Dziurdzik *Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, University of British Columbia , Vancouver, Canada.ORCID 0000-0002-3553-1595
Vaishnavi Sridhar *Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, University of British Columbia , Vancouver, Canada.ORCID 0000-0002-1157-7468
Hailey EngCentre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, University of British Columbia , Vancouver, Canada.ORCID 0009-0003-0947-8043
Sarah D NeumanDivision of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0001-5731-6426
Junran YanCentre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, University of British Columbia , Vancouver, Canada.ORCID 0009-0003-6793-123X
Michael DaveyCentre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, University of British Columbia , Vancouver, Canada.ORCID 0000-0002-1172-5934
Stefan TaubertCentre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, University of British Columbia , Vancouver, Canada.ORCID 0000-0002-2432-7257
Arash BashirullahDivision of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0001-7150-1775
Elizabeth ConibearCentre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, University of British Columbia , Vancouver, Canada.ORCID 0000-0001-5129-0499

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
Analysis of Bulk Lipid Transport at Membrane Contact SitesR01GM155154 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI ARASH BASHIRULLAH, TIMOTHY S BUGNI · 2024 to 2026
$1.5M
BC Children's HospitalBloomington Drosophila Stock CenterCanada Foundation for Innovation 30636CIHR OGB-177941CIHR PJT-153199CIHR PJT-180544Department of Science and Technology, Scientific and Engineering Research BoardGS-D Frederick Banting and Charles Best Canada Graduate ScholarshipNatural Sciences and Engineering Research Council of Canada RGPIN-2018-05133Natural Sciences and Engineering Research Council of Canada RGPIN-2022-04573NIGMS NIH HHS R01 GM155154NIH HHS 1R01GM155154NIH HHS P40 OD018537ODCDC CDC HHS P40 OD010440
6 · The paper itself

Abstract

Membrane contact sites between organelles are important for maintaining cellular lipid homeostasis. Members of the recently identified family of bridge-like lipid transfer proteins (BLTPs) span apposing membranes at these contact sites to enable the rapid transfer of bulk lipids between organelles. While the VPS13 and ATG2 family members use organelle-specific adaptors for membrane targeting, the mechanisms that regulate other bridge-like transporters are unclear. Here, we identify the conserved protein Ybl086c, which we name Hob interactor 1 (Hoi1), as an adaptor that targets the yeast BLTP2-like proteins Fmp27/Hob1 and Hob2 to ER-plasma membrane (PM) contact sites. Two separate Hoi1 domains interface with α-helical projections that decorate the central hydrophobic channel on Fmp27, and loss of these interactions alters cellular sterol homeostasis. The mutant phenotypes of BLTP2 and HOI1 orthologs indicate these proteins act in a shared pathway in worms and flies. Together, this suggests that Hoi1-mediated recruitment of BLTP2-like proteins represents an evolutionarily conserved mechanism for regulating lipid transport at membrane contact sites.

Indexed as

Carrier ProteinsCell MembraneEndoplasmic ReticulumLipid MetabolismSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAnimalsHomeostasisSterolsCarrier Proteinslipid transfer proteinSaccharomyces cerevisiae ProteinsSterols

Identifiers

PMID41746219
PMCPMC13126230

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.